Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TASP1 | Q9H6P5 | 1/20 | 0.49 |
| ▸ | GZMB | P10144 | 3/20 | 0.44 |
| ▸ | ENPEP | Q07075 | 11/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20257131 | 0.88 | TASP1 (0.52) | TASP1GZMBENPEP | |
| SCHEMBL2381289 | 0.88 | TASP1 (0.52) | TASP1GZMBENPEP | |
| SCHEMBL23924919 | 0.88 | TASP1 (0.52) | TASP1GZMBENPEP | |
| SCHEMBL23132679 | 0.88 | TASP1 (0.52) | TASP1GZMBENPEP | |
| SCHEMBL23133165 | 0.88 | TASP1 (0.52) | TASP1GZMBENPEP | |
| SCHEMBL15485472 | 0.86 | ENPEP (0.39) | TASP1ENPEP | |
| SCHEMBL5746872 | 0.85 | TASP1 (0.61) | TASP1GZMBENPEP | |
| SCHEMBL2787269 | 0.83 | GZMB (0.49) | TASP1GZMB | |
| SCHEMBL20257263 | 0.80 | TASP1 (0.53) | TASP1GZMBENPEP | |
| SCHEMBL20257260 | 0.80 | TASP1 (0.53) | TASP1GZMBENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140056964-A1 | GRANZYME B INHIBITOR COMPOSITIONS, METHODS AND USES FOR PROMOTING WOUND HEALING | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2014-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140056964-A1 | GRANZYME B INHIBITOR COMPOSITIONS, METHODS AND USES FOR PROMOTING WOUND HEALING | GZMB, PRF1, SERPINB1 | TASP1 3637/4885GZMB 1/4885ENPEP 319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.